Core Laboratories Inc

Core Laboratories Inc(CLB)股票分析

$10.000

+0.225 (+2.25%)收盘时

Loading chart…
最高
10.095
开盘
9.920
成交量加权均价
9.99
成交量
385.13K
市值
922.56M
最低
9.880
成交额
3.85M
企业价值/息税折旧摊销前利润(TTM)
11.05

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

AI 分析 of Core Laboratories Inc (CLB)

持有

Core Laboratories Inc is currently a hold. The stock is trading at $10, which is significantly below its analyst price target of $21, indicating potential upside. However, the RSI is at 46.267, suggesting it is neither overbought nor oversold, and the stock has a year-to-date decline of 41%, indicating ongoing weakness. The main risk is the recent downgrade from BofA, which lowered its price target to $11, reflecting concerns about future performance.

分析师评级(18)

上行空间 +15.00%
买入
10 买入
8 持有
0 卖出
当前: 10.00
最低
11.50
平均
11.50
最高
11.50

Johnson Rice

2026-08-13

目标价

$21

买入

BofA

2026-07-15

目标价

$11

跑输大盘

Stifel

2025-07-16

目标价

$12

持有

Citi

2025-05-13

目标价

$13

中性

Stifel

2025-04-25

目标价

$13

持有

估值指标

Core Laboratories Inc(CLB)当前预期市盈率为 19.76,5 年平均预期市盈率为 23.29。

预期市盈率

合理
5 年均值 P/E
23.29
当前P/E
19.76
高估
31.54
低估
15.04

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.97
当前EV/EBITDA
11.05
高估
19.91
低估
10.02

预期市销率

低估
5 年均值 P/S
1.67
当前P/S
0.86
高估
2.16
低估
1.17

Alphio AI 对 CLB 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CLB

$12.15

情景价格

基

基准

基准 · 50%CLB

$11.83

情景价格

悲

悲观

悲观 · 25%CLB

$9.77

情景价格

持有 CLB 的大户

C

CWA Asset Management Group, LLC

+ 持有CLB

+5.40%

3个月收益率

A

Ariel Investments, LLC

+ 持有CLB

-4.43%

3个月收益率

事件时间线

2026-07-29 (ET)

17:30:00

Sees Q3 Revenue of $128.5M-$135.5M

17:30:00

Core Lab Reports Q2 Revenue of $124.6M

2026-06-26 (ET)

17:30:00

S&P Global to Spin Off Mobility Global on July 1

2026-04-29 (ET)

17:00:00

Core Lab Q1 Revenue at $121.8M, Below Consensus

17:00:00

Sees Q2 Revenue of $123M-$131M

资讯

CLB 常见问题 —— 由 Alphio AI 解答

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. It operates in the Industrials sector (OIL & GAS FIELD SERVICES, NEC industry).

Core Laboratories Inc is currently a hold. The stock is trading at $10, which is significantly below its analyst price target of $21, indicating potential upside. However, the RSI is at 46.267, suggesting it is neither overbought nor oversold, and the stock has a year-to-date decline of 41%, indicating ongoing weakness. The main risk is the recent downgrade from BofA, which lowered its price target to $11, reflecting concerns about future performance.

18 analysts cover CLB: 10 rate it Buy, 8 Hold and 0 Sell. The average price target is 11.50.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易